Tag Archives: CNS

July, 2018

June, 2018

November, 2017

September, 2017

May, 2017

April, 2017

August, 2016

  • 2 August

    Pfizer Acquires Gene Therapy Company Bamboo Therapeutics

    Pfizer Inc. (NYSE:PFE) today announced that it has acquired Bamboo Therapeutics, Inc., a privately held biotechnology company based in Chapel Hill, N.C., focused on developing gene therapies for the potential treatment of patients with certain rare diseases related to neuromuscular conditions and those affecting the central nervous system. This acquisition …

July, 2016

  • 20 July

    An Antibody-Based Drug for Multiple Sclerosis

    Inserm Unit U919, directed by Prof. Denis Vivien (“Serine Proteases and Physiopathology of the Neurovascular Unit”) has developed an antibody with potential therapeutic effects against multiple sclerosis. The study, directed by Fabian Docagne and published in Brain, paves the way for a new strategy to control the disease. Multiple sclerosis …

May, 2016

January, 2016